Process for the industrial synthesis of isoindoline by catalytic hydrogenation of phthalonitrile.
Application in the synthesis of 2-(S)-benzyl-4-oxo-4-(cis-perhydroisoindol-2-yl)-butyric acid, its pharmaceutically acceptable salts and its hydrates.
Stereoelectronic suppression and a remarkably low effective concentration for a cyclization to a benzo-fused five-membered ring
作者:James F. King、Joe Y. L. Lam、Stanis?aw Skonieczny
DOI:10.1039/c39880000147
日期:——
The cyclization of o-chloromethylbenzylamine to dihydroisoindole has an effectiveconcentration of 8.3 M(in CD3OD at 21 °C); this very low value for a cyclization to a benzo-fusedfive-memberedring is ascribed to lessened conjugation in the transition state as compared to that of the model reaction, and is relevant to both the synthesis of rings and the application of effectiveconcentrations in obtaining
[1,2,3]TRIAZOLO[4,5-D]PYRIMIDINE DERIVATIVES WITH AFFINITY FOR THE TYPE-2 CANNABINOID RECEPTOR
申请人:F. Hoffmann-La Roche AG
公开号:EP4108665A1
公开(公告)日:2022-12-28
The invention relates to a compound of formula (I)
wherein R1 to R4 and n are defined as in the description and in the claims. The compound of formula (I) can be used as a medicament.
本发明涉及一种式 (I) 的化合物
其中 R1 至 R4 和 n 的定义见说明书和权利要求书。式(I)化合物可用作药物。
[1,2,3]triazolo[4,5-D]pyrimidine derivatives with affinity for the type-2 cannabinoid receptor
申请人:Hoffmann-La Roche Inc.
公开号:US10457685B2
公开(公告)日:2019-10-29
The invention relates to a compound of formula (I)
wherein R1 to R4 and n are defined as in the description and in the claims. The compound of formula (I) can be used as a medicament.
本发明涉及一种式 (I) 的化合物
其中 R1 至 R4 和 n 的定义见说明书和权利要求书。式(I)化合物可用作药物。
One-Pot Preparation of Cyclic Amines from Amino Alcohols